European Leukemia Trial Registry
Trial: AIDA2009

More Details
Scientific Title Recommendations for risk adapted treatment of acute promyelocytic leukemia in the AML-SAL-Study group - an observational study -
Short Title AIDA2009
Trialgroup SAL
Type of Trial multicentric
Disease Acute myeloid leukemia(AML) FAB M3 (APL)
Age >= 18 years
Status Closed
Start of Recruitment 19.10.2009
Contactperson

principal investigator
Platzbecker, Prof. Dr. med., Uwe
Tel: +49 (0)351 4582583
Fax: +49 (0)351 458-5362
Email: Uwe.Platzbecker@uniklinikum-dresden.de

Study Centre
Peschel, Katrin
Tel: +49 (0)351 458 5222
Email: katrin.peschel@uniklinikum-dresden.de

Shortprotocol Shortprotocol
Remark ATRA and chemotherapy followed by Maintenance therapy with chemotherapy and ATRA; www.sal-aml.org
created 15.06.2010 Johannes Kraus
changed 28.08.2014 Johannes Kraus
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org